Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02024607
Title A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

colorectal adenocarcinoma

hepatocellular carcinoma

pancreatic adenocarcinoma

gastric adenocarcinoma

cholangiocarcinoma

Therapies

Capecitabine + Oxaliplatin

Bevacizumab + Napabucasin

Napabucasin + Regorafenib

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Napabucasin

Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.